C: | CHEMISTRY; METALLURGY | |
C07: | ORGANIC CHEMISTRY | |
C07K: | PEPTIDES | |
C07K1/00: | General methods for the preparation of peptides [N: i.e. processes for the organic chemical preparation of peptides or proteins of any length] | |
C07K1/00A: | . [N: by transforming the C-terminal amino acid to amides] | |
C07K1/00B: | . of peptides containing derivatised side chain amino acids | |
C07K1/02: | . in solution C07K1/00A, C07K1/00B take precedence | |
C07K1/02A: | . . using racemisation inhibiting agents | |
C07K1/02B: | . . [N: by fragment condensation in solution] | |
C07K1/04: | . on carriers C07K1/00A, C07K1/00B take precedence | |
C07K1/04A: | . . characterised by the nature of the carrier | |
C07K1/04B: | . . using devices to improve synthesis, e.g. reactors, special vessels | |
C07K1/04C: | . . Simultaneous synthesis of different peptide species; Peptide libraries | |
C07K1/06: | . using protecting groups or activating agents C07K1/00A, C07K1/00B take precedence | |
C07K1/06A: | . . using protecting groups | |
C07K1/06A1: | . . . for alpha- or omega-carboxy functions | |
C07K1/06A2: | . . . for alpha-amino functions | |
C07K1/06A3: | . . . for omega-amino or -guanidino functions | |
C07K1/06A4: | . . . for hydroxy functions, not being part of carboxy functions | |
C07K1/06A5: | . . . for omega-amido functions | |
C07K1/06A6: | . . . for sulfur-containing functions | |
C07K1/06A7: | . . . for heterocyclic side chains | |
C07K1/08: | . . using activating agents C07K1/00A, C07K1/00B take precedence | |
C07K1/08A: | . . . containing phosphorus | |
C07K1/08B: | . . . containing nitrogen | |
C07K1/08C: | . . . containing sulfur | |
C07K1/08D: | . . . containing other elements, e.g. B, Si, As | |
C07K1/10: | . using coupling agents C07K1/00B takes precedence | |
C07K1/107: | . by chemical modification of precursor peptides | |
C07K1/107D: | . . by covalent attachment of residues or functional groups | |
C07K1/107D2: | . . . by covalent attachment of amino acids or peptide residues | |
C07K1/107D4: | . . . by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids | |
C07K1/113: | . . without change of the primary structure | |
C07K1/113B: | . . . [N: by redox-reactions involving cystein/cystin side chains] | |
C07K1/113D: | . . . [N: by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents] | |
C07K1/113D2: | . . . . and redox-reactions involving cystein/cystin sidechains | |
C07K1/113D2C: | . . . . . with mixed disulfides or sulfonates as stable intermediates | |
C07K1/113D2F: | . . . . . using an enzyme which catalyses the formation of disulfide bonds | |
C07K1/12: | . by hydrolysis i.e. solvolysis in general | |
C07K1/12A: | . . Hydrolysis with acids different from HF | |
C07K1/12C: | . . Hydrazinolysis | |
C07K1/12D: | . . Aminolysis | |
C07K1/12E: | . . [N: sequencing] | |
C07K1/13: | . Labelling of peptides | |
C07K1/14: | . Extraction; Separation; Purification | |
C07K1/14A: | . . [N: by extraction or solubilisation] | |
C07K1/16: | . . by chromatography | |
C07K1/16A: | . . . [N: mixed-mode chromatography] | |
C07K1/18: | . . . Ion-exchange chromatography | |
C07K1/20: | . . . Partition-, reverse-phase or hydrophobic interaction chromatography | |
C07K1/22: | . . . Affinity chromatography or related techniques based upon selective absorption processes | |
C07K1/24: | . . by electrochemical means | |
C07K1/26: | . . . Electrophoresis | |
C07K1/28: | . . . . Isoelectric focusing | |
C07K1/28A: | . . . . . [N: multi dimensional electrophoresis] | |
C07K1/30: | . . by precipitation | |
C07K1/30A: | . . . [N: by salting out] | |
C07K1/30B: | . . . by crystallization | |
C07K1/32: | . . . as complexes | |
C07K1/34: | . . by filtration, ultrafiltration or reverse osmosis | |
C07K1/36: | . . by a combination of two or more processes of different types | |
C07K2/00: | Peptides of undefined number of amino acids; Derivatives thereof | |
C07K4/00: | Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof | |
C07K4/02: | . from viruses | |
C07K4/04: | . from bacteria | |
C07K4/06: | . from fungi | |
C07K4/08: | . from algae; from lichens | |
C07K4/10: | . from plants | |
C07K4/12: | . from animals; from humans | |
C07K5/00: | Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof | |
C07K5/02: | . containing at least one abnormal peptide link | |
C07K5/02A: | . . containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids | |
C07K5/02B: | . . containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof | |
C07K5/02C: | . . containing the structure -NH-(X)4-C(=0), e.g. `isosters`, replacing two amino acids | |
C07K5/02D: | . . 6, classification in C07K5/06 to C07K5/10, according to the moiety having normal peptide bonds | |
C07K5/02E: | . . containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides | |
C07K5/02F: | . . containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu | |
C07K5/02G: | . . containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)- | |
C07K5/02H: | . . containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 | |
C07K5/02H1: | . . . [N: with the first amino acid being heterocyclic, e.g. Pro, Trp] | |
C07K5/02H1A: | . . . . , A being an organic radical and Y being a heteroatom | |
C07K5/02H1A1: | . . . . . containing the partial structure -amino acid-Pro | |
C07K5/02J: | . . containing the structure -N-C-C(=O)-N-C(=O)-C-N- | |
C07K5/02L: | . . 6 see C07K5/06 to C07K5/10 | |
C07K5/02L2: | . . . -Phe-His-NH-(X)2-C(=0)- | |
C07K5/02L3: | . . . -Phe-His-NH-(X)3-C(=0)- (containing statine or derivatives) | |
C07K5/02L4: | . . . -Phe-His-NH-(X)4-C(=0)- (containing `isosters`) | |
C07K5/02L5: | . . . -Phe-His-NH-(X)n-C(=0)-, with n = 5 or 6 | |
C07K5/04: | . containing only normal peptide links | |
C07K5/06: | . . Dipeptides | |
C07K5/06A: | . . . with the first amino acid being neutral | |
C07K5/06A1: | . . . . and aliphatic | |
C07K5/06A1A: | . . . . . the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala | |
C07K5/06A1A1: | . . . . . . with the second amino acid being neutral | |
C07K5/06A1A1A: | . . . . . . . and aromatic or cycloaliphatic | |
C07K5/06A1A2: | . . . . . . with the second amino acid being basic | |
C07K5/06A1A3: | . . . . . . with the second amino acid being acidic | |
C07K5/06A1B: | . . . . . the side chain containing 2 to 4 carbon atoms | |
C07K5/06A1B1: | . . . . . . Leu-amino acid | |
C07K5/06A1B2: | . . . . . . Val-amino acid | |
C07K5/06A1C: | . . . . . the side chain containing a least 5 carbon atoms | |
C07K5/06A1F: | . . . . . the side chain containing heteroatoms not provided for by C07K5/06B to C07K5/06H, e.g. Ser, Met, Cys, Thr | |
C07K5/06A1F1: | . . . . . . Ser-amino acid | |
C07K5/06A1G: | . . . . . , with X being an iso- or heterocyclic radical, R being H or a substituent and Y being a heteroatom | |
C07K5/06A1H: | . . . . . with the second amino acid being heterocyclic | |
C07K5/06A1H1: | . . . . . .
with A being an organic radical and Y being a heteroatom | |
C07K5/06A1H1A: | . . . . . . . Amino acid-Pro | |
C07K5/06A2: | . . . . [N: and aromatic or cycloaliphatic] | |
C07K5/06B: | . . . with the first amino acid being basic | |
C07K5/06B1: | . . . . Arg-amino acid | |
C07K5/06C: | . . . with the first amino acid being acidic | |
C07K5/06C1: | . . . . Asp- or Asn-amino acid | |
C07K5/06C1A: | . . . . . the second amino acid being aromatic or cycloaliphatic | |
C07K5/06C1A1: | . . . . . . Aspartame | |
C07K5/06C1A1A: | . . . . . . . Purification, e.g. chromatography, electrophoresis, dialysis | |
C07K5/06C1A1B: | . . . . . . . [N. Salting out] | |
C07K5/06C1A1C: | . . . . . . . Crystallisation including drying methods | |
C07K5/06C1A1D: | . . . . . . . Preparation by enzymatic methods, e.g. enzyme-induced hydrolysis or coupling | |
C07K5/06H: | . . . with the first amino acid being heterocyclic | |
C07K5/06H1: | . . . . Dipeptides with the partial structure NH2-CH(heterocycle)-C(=0)-amino acid | |
C07K5/06H1A: | . . . . . His-amino acid; derivatives thereof | |
C07K5/06H1B: | . . . . . Trp-amino acid; derivatives thereof | |
C07K5/06H2: | . . . .
with A being an organic radical and wherein the ring can be unsaturated | |
C07K5/06H2A: | . . . . . Pro-amino acid; Derivatives thereof | |
C07K5/06H2B: | . . . . . Glp-amino acid; Derivatives thereof[C9501] | |
C07K5/06H2C: | . . . . . Pristinamycin II; Derivatives thereof[C9501] | |
C07K5/06H3: | . . . . and His-amino acid; Derivatives thereof | |
C07K5/06H4: | . . . .
with A being an organic radical, R being H or a substituent, and Y being a heteroatom | |
C07K5/06H5: | . . . . [N: and Trp-amino acid; Derivatives thereof ] | |
C07K5/06H6: | . . . . [N: and Pro-amino acid; Derivatives thereof] | |
C07K5/06H7: | . . . . and Glp-amino acid; Derivatives thereof | |
C07K5/06H8: | . . . . [N: and Pristinamycin II; Derivatives thereof] | |
C07K5/06P: | . . . containing phosphorus | |
C07K5/06T: | . . . [N: containing heteroatoms different from O, S, or N ] | |
C07K5/08: | . . Tripeptides | |
C07K5/08A: | . . . with the first amino acid being neutral | |
C07K5/08A1: | . . . . and aliphatic | |
C07K5/08A1A: | . . . . . the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala [M1208] | |
C07K5/08A1B: | . . . . . the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu | |
C07K5/08A1F: | . . . . . the side chain containing O or S as heteroatoms, e.g. Cys, Ser | |
C07K5/08A2: | . . . . and aromatic or cycloaliphatic | |
C07K5/08B: | . . . with the first amino acid being basic | |
C07K5/08B1: | . . . . the first amino acid being Arg | |
C07K5/08C: | . . . with the first amino acid being acidic | |
C07K5/08C1: | . . . . Asp-X-Y, Asn-X-Y, or derivatives thereof, X and Y being amino acids | |
C07K5/08H: | . . . [N: with the first amino acid being heterocyclic, e.g. His, Pro, Trp] | |
C07K5/08H1: | . . . . having the partial structure NH2-CH(heterocycle)-C(=O)-(amino acid)2 | |
C07K5/08H2: | . . . .
with A being an organic radical | |
C07K5/08H2A: | . . . . . Pro-amino acid; Derivatives thereof[N9501] | |
C07K5/08H2B: | . . . . . Glp-amino acid; Derivatives thereof[N9501] | |
C07K5/08H3: | . . . .
with A being an organic radical and R being H or a substituent | |
C07K5/08H4: | . . . . [N: and Pro-amino acid; Derivatives thereof] | |
C07K5/08H5: | . . . . [N: and Glp-amino acid; Derivatives thereof] | |
C07K5/08P: | . . . containing phosphorus | |
C07K5/08T: | . . . [N: containing heteroatoms different from O, S, or N ] | |
C07K5/10: | . . Tetrapeptides | |
C07K5/10A: | . . . with the first amino acid being neutral | |
C07K5/10A1: | . . . . and aliphatic | |
C07K5/10A1A: | . . . . . the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala | |
C07K5/10A1B: | . . . . . the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu | |
C07K5/10A1F: | . . . . . the side chain containing O or S as heteroatoms, e.g. Cys, Ser | |
C07K5/10A2: | . . . . and aromatic or cycloaliphatic | |
C07K5/10B: | . . . with the first amino acid being basic | |
C07K5/10C: | . . . with the first amino acid being acidic | |
C07K5/10C1: | . . . . Asp-X-Y-Z, Asn-X-Y-Z, or derivatives thereof, X, Y and Z being amino acids | |
C07K5/10H: | . . . with the first amino acid being heterocyclic | |
C07K5/10P: | . . . containing phosphorus | |
C07K5/10T: | . . . [N: containing heteroatoms different from O, S, or N ] | |
C07K5/10V: | . . . containing the sequence Arg-Gly-Asp | |
C07K5/12: | . . Cyclic peptides with only normal peptide bonds in the ring | |
C07K5/12A: | . . . Tripeptides | |
C07K5/12B: | . . . Tetrapeptides | |
C07K7/00: | Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof | |
C07K7/02: | . Linear peptides containing at least one abnormal peptide link | |
C07K7/04: | . Linear peptides containing only normal peptide links | |
C07K7/06: | . . having 5 to 11 amino acids | |
C07K7/06A: | . . . with all amino acids in L-form | |
C07K7/06B: | . . . with at least one amino acid in D-form | |
C07K7/06D: | . . . Serum thymic factor | |
C07K7/06E: | . . . Thymic humoral factor | |
C07K7/06F: | . . . Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys | |
C07K7/08: | . . having 12 to 20 amino acids | |
C07K7/08A: | . . . with all amino acids in L-form | |
C07K7/08B: | . . . with at least one amino acid in D-form | |
C07K7/08C: | . . . Neurotensin | |
C07K7/08D: | . . . Bombesin; Related peptides having more than 20 amino acids C07K14/575M | |
C07K7/14: | . . Angiotensins: Related peptides | |
C07K7/16: | . . Oxytocins; Vasopressins; Related peptides | |
C07K7/18: | . . Kallidins; Bradykinins; Related peptides | |
C07K7/22: | . . Tachykinins, e.g. Eledoisins, Substance P ; Related peptides | |
C07K7/23: | . . Luteinising hormone-releasing hormone (LHRH); Related peptides | |
C07K7/28: | . . Gramicidins A, B, D; Related peptides | |
C07K7/50: | . Cyclic peptides containing at least one abnormal peptide link | |
C07K7/52: | . . with only normal peptide links in the ring | |
C07K7/54: | . . with at least one abnormal peptide link in the ring | |
C07K7/56: | . . . the cyclisation not occuring through 2,4-diamino-butanoic acid | |
C07K7/58: | . . . . Bacitracins; Related peptides | |
C07K7/60: | . . . the cyclisation occuring through the 4-amino group of 2,4-diamino-butanoic acid | |
C07K7/62: | . . . . Polymyxins; Related peptides | |
C07K7/64: | . Cyclic peptides containing only normal peptide links | |
C07K7/64A: | . . Cyclosporins; Related peptides | |
C07K7/66: | . . Gramicidins S, C; Tyrocidins A,B,C; Related peptides | |
C07K9/00: | Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof | |
C07K9/00D: | . the peptide sequence having less than 12 amino acids and not being part of a ring structure | |
C07K9/00D2: | . . Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin | |
C07K9/00D4: | . . 0, A,B,D,E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides | |
C07K9/00F: | . the peptide sequence being part of a ring structure | |
C07K9/00F2: | . . directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin | |
C07K11/00: | Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof | |
C07K11/02: | . cyclic, e.g. valinomycins Derivatives thereof | |
C07K14/00: | Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof | |
C07K14/005: | . from viruses | |
C07K14/00B: | . by chemical synthesis | |
C07K14/00B1: | . . Peptide-nucleic acids (PNAs) | |
C07K14/01: | . . DNA viruses | |
C07K14/015: | . . . Parvoviridae, e.g. feline panleukopenia virus, human parvovirus | |
C07K14/02: | . . . Hepadnaviridae, e.g. hepatitis B virus | |
C07K14/025: | . . . Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus | |
C07K14/03: | . . . Herpetoviridae, e.g. pseudorabies virus | |
C07K14/035: | . . . . Herpes simplex virus I or II | |
C07K14/03B: | . . . . Pseudorabies virus, i.e. Anjetzky virus | |
C07K14/04: | . . . . Varicella-zoster virus | |
C07K14/045: | . . . . . Cytomegalovirus | |
C07K14/05: | . . . . Epstein-Barr virus | |
C07K14/055: | . . . . Marek`s disease virus | |
C07K14/06: | . . . . Infectious bovine rhinotracheitis virus | |
C07K14/065: | . . . Poxviridae, e.g. avipoxvirus | |
C07K14/07: | . . . . Vaccinia virus; Variola virus | |
C07K14/075: | . . . Adenoviridae | |
C07K14/08: | . . RNA viruses | |
C07K14/085: | . . . Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus | |
C07K14/08C: | . . . Arteriviridae, e.g. EAV, PRRSV | |
C07K14/09: | . . . . Foot-and-mouth disease virus | |
C07K14/095: | . . . . Rhinovirus | |
C07K14/10: | . . . . Hepatitis A virus | |
C07K14/105: | . . . . Poliovirus | |
C07K14/11: | . . . Orthomyxoviridae, e.g. influenza virus | |
C07K14/115: | . . . Paramyxoviridae, e.g. parainfluenza virus | |
C07K14/12: | . . . . Mumps virus; Measles virus | |
C07K14/125: | . . . . Newcastle disease virus | |
C07K14/13: | . . . . Canine distemper virus | |
C07K14/135: | . . . . Respiratory syncytial virus | |
C07K14/14: | . . . Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus | |
C07K14/145: | . . . Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokda virus, vesicular stomatitis virus | |
C07K14/15: | . . . Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus | |
C07K14/155: | . . . . Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV | |
C07K14/16: | . . . . . HIV-1; HIV-2 | |
C07K14/165: | . . . Coronaviridae, e.g. avian infectious bronchitis virus | |
C07K14/16B: | . . . . . . gag-pol, e.g. p55, p24/25, p17/18, p7, p6, p66/68, p51/52, p31/34, p32, p40 | |
C07K14/16D: | . . . . . . env, e.g. gp160, gp110/120, gp41, V3, peptid T, CD4-Binding site | |
C07K14/16F: | . . . . . . Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx | |
C07K14/17: | . . . . Porcine transmissible gastroenteritis virus | |
C07K14/175: | . . . Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus | |
C07K14/18: | . . . Togaviridae; Flaviviridae | |
C07K14/18A: | . . . . Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE, semliki forest virus rubella virus C07K14/19 | |
C07K14/18F: | . . . . Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus | |
C07K14/18F2: | . . . . . Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue | |
C07K14/18F4: | . . . . . Hepatitis C; Hepatitis NANB | |
C07K14/18F6: | . . . . . Hepatitis G; Hepatitis NANBNCNDNE | |
C07K14/19: | . . . . Rubella virus | |
C07K14/195: | . from bacteria | |
C07K14/20: | . . from Spirochaetales (O), e.g. Treponema, Leptospira | |
C07K14/205: | . . from Campylobacter (G) | |
C07K14/21: | . . from Pseudomonadaceae (F) | |
C07K14/215: | . . from Halobacteriaceae (F) | |
C07K14/21B: | . . . Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter | |
C07K14/22: | . . from Neisseriaceae (F) | |
C07K14/225: | . . from Alcaligenes (G) | |
C07K14/23: | . . from Brucella (G) | |
C07K14/235: | . . from Bordetella (G) | |
C07K14/24: | . . from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia | |
C07K14/245: | . . . Escherichia (G) | |
C07K14/25: | . . . Shigella (G) | |
C07K14/255: | . . . Salmonella (G) | |
C07K14/26: | . . . Klebsiella (G) | |
C07K14/265: | . . . Enterobacter (G) | |
C07K14/27: | . . . Erwinia (G) | |
C07K14/275: | . . . Hafnia (G) | |
C07K14/28: | . . from Vibrionaceae (F) | |
C07K14/285: | . . from Pasteurellaceae (F), e.g. Haemophilus influenza | |
C07K14/29: | . . from Richettsiales (o) | |
C07K14/295: | . . from Chlamydiales (o) | |
C07K14/30: | . . from Mycoplasmatales, e.g. Pleuropneumonia-like organisms (PPLO) | |
C07K14/305: | . . from Micrococcaceae (F) | |
C07K14/31: | . . . from Staphylococcus (G) | |
C07K14/315: | . . from Streptococcus (G), e.g. Enterococci | |
C07K14/315A: | . . . Streptokinase | |
C07K14/315B: | . . . from Streptococcus pneumoniae (Pneumococcus) Streptokinase C07K14/315A | |
C07K14/32: | . . from Bacillus (G) | |
C07K14/325: | . . . Bacillus thuringiensis crystal protein (delta-endotoxin) | |
C07K14/33: | . . from Clostridium (G) | |
C07K14/335: | . . from Lactobacillus (G) | |
C07K14/34: | . . from Corynebacterium (G) | |
C07K14/345: | . . from Brevibacterium (G) | |
C07K14/35: | . . from Mycobacteriaceae (F) | |
C07K14/355: | . . from Nocardia (G) | |
C07K14/36: | . . from Actinomyces; from Streptomyces (G) | |
C07K14/365: | . . from Actinoplanes (G) | |
C07K14/37: | . from fungi | |
C07K14/375: | . . from Basidiomycetes | |
C07K14/38: | . . from Aspergillus | |
C07K14/385: | . . from Penicillium | |
C07K14/39: | . . from yeasts | |
C07K14/395: | . . . from Saccharomyces | |
C07K14/40: | . . . from Candida | |
C07K14/405: | . from algae | |
C07K14/41: | . from lichens | |
C07K14/415: | . from plants | |
C07K14/42: | . . Lectins, e.g. concanavalin, phytohaemagglutinin | |
C07K14/425: | . . Zeins | |
C07K14/43: | . . Sweetening agents, e.g. thaumatin, monellin | |
C07K14/435: | . from animals; from humans | |
C07K14/435A: | . . from invertebrates | |
C07K14/435A1: | . . . from crustaceans | |
C07K14/435A2: | . . . from arachnidae | |
C07K14/435A2A: | . . . . from spiders | |
C07K14/435A2B: | . . . . from scorpions | |
C07K14/435A2C: | . . . . from ticks | |
C07K14/435A2D: | . . . . from mites | |
C07K14/435A3: | . . . from worms | |
C07K14/435A3A: | . . . . from nematodes | |
C07K14/435A3A1: | . . . . . from Caenorhabditis | |
C07K14/435A3B: | . . . . from cestodes | |
C07K14/435A3B1: | . . . . . from Taenia | |
C07K14/435A3C: | . . . . from trematodes | |
C07K14/435A4: | . . . from insects | |
C07K14/435A4A: | . . . . from ticks[N9604] | |
C07K14/435A4B: | . . . . from wasps | |
C07K14/435A4C: | . . . . from bees | |
C07K14/435A4D: | . . . . from flies | |
C07K14/435A4D1: | . . . . . from Drosophila | |
C07K14/435A4E: | . . . . from silkworms [M1204] | |
C07K14/435A4F: | . . . . from mites[N9604] | |
C07K14/435A4G: | . . . . from fleas | |
C07K14/435A5: | . . . from coelenteratae, e.g. medusae | |
C07K14/44: | . . from protozoa | |
C07K14/445: | . . . Plasmodium | |
C07K14/45: | . . . Toxoplasma | |
C07K14/455: | . . . Eimeria | |
C07K14/46: | . . from vertebrates | |
C07K14/465: | . . . from birds | |
C07K14/46A: | . . . from fish | |
C07K14/46B: | . . . from amphibians | |
C07K14/47: | . . . from mammals | |
C07K14/475: | . . Growth factors; Growth regulators | |
C07K14/475A: | . . . Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II | |
C07K14/475B: | . . . Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor | |
C07K14/47A: | . . . . not used | |
C07K14/47A1: | . . . . . Regulators; Modulating activity | |
C07K14/47A11: | . . . . . Complement proteins, e.g. anaphylatoxin, C3a, C5a | |
C07K14/47A12: | . . . . . Lipocortins | |
C07K14/47A13: | . . . . . G-proteins | |
C07K14/47A14: | . . . . . Cationic antimicrobial peptides, e.g. defensins | |
C07K14/47A15: | . . . . . Proteoglycans, e.g. aggreccan | |
C07K14/47A16: | . . . . . Lectins | |
C07K14/47A17: | . . . . . Mucins, e.g. human intestinal mucin | |
C07K14/47A18: | . . . . . Calcium binding proteins, e.g. calmodulin | |
C07K14/47A19: | . . . . . alpha-Glycoproteins | |
C07K14/47A1A: | . . . . . . Inhibitors; Supressors | |
C07K14/47A1B: | . . . . . . stimulating, promoting or activating activity | |
C07K14/47A1B1: | . . . . . . . Guanosine triphosphatase activating protein, GAP | |
C07K14/47A2: | . . . . . Muscular dystrophy | |
C07K14/47A20: | . . . . . Recognins, e.g. malignin | |
C07K14/47A21: | . . . . . Casein in foodstuffs A23J | |
C07K14/47A22: | . . . . . Acute pancreatitis-associated protein | |
C07K14/47A23: | . . . . . Villin | |
C07K14/47A24: | . . . . . Retinoblastoma protein | |
C07K14/47A25: | . . . . . C-reactive protein | |
C07K14/47A26: | . . . . . Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR cell cycle dependent kinases C12N9/12B1 | |
C07K14/47A27: | . . . . . Pancreatic thread protein; Reg protein | |
C07K14/47A28: | . . . . . Keratin; Cytokeratin | |
C07K14/47A29: | . . . . . Bactericidal/Permeability-increasing protein (BPI) | |
C07K14/47A2A: | . . . . . . Duchenne dystrophy | |
C07K14/47A2B: | . . . . . . Myotonic dystrophy | |
C07K14/47A3: | . . . . . Alzheimer`s disease; Amyloid plaque core protein | |
C07K14/47A30: | . . . . . Insulin-like growth factor binding protein | |
C07K14/47A31: | . . . . . Cancer-associated SCM-recognition factor, CRISPP | |
C07K14/47A32: | . . . . . p53 | |
C07K14/47A33: | . . . . . Apoptosis related proteins | |
C07K14/47A34: | . . . . . Tumour specific antigens; Tumour rejection antigen precursors (TRAP), e.g. MAGE | |
C07K14/47A4: | . . . . . Cystic fibrosis | |
C07K14/47A5: | . . . . . Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens | |
C07K14/47A6: | . . . . . Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein | |
C07K14/47A7: | . . . . . Muscle proteins, e.g. myosin, actin [M1204] | |
C07K14/47A8: | . . . . . Plasma globulins, lactoglobulin | |
C07K14/47A9: | . . . . . Cytokine-induced proteins | |
C07K14/48: | . . . Nerve growth factor (NGF) | |
C07K14/485: | . . . Epidermal growth factor (EGF) (urogastrone) | |
C07K14/49: | . . . Platelet-derived growth factor (PDGF) | |
C07K14/495: | . . . Transforming growth factor (TGF) | |
C07K14/50: | . . . Fibroblast growth factors (FGF) | |
C07K14/505: | . . . Erythropoietin (EPO) | |
C07K14/50A: | . . . . acidic FGF (aFGF) | |
C07K14/50B: | . . . . basic FGF (bFGF) | |
C07K14/51: | . . . Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor | |
C07K14/515: | . . . Angiogenesic factors; Angiogenin | |
C07K14/52: | . . Cytokines; Lymphokines; Interferons | |
C07K14/525: | . . . Tumor necrosis factor (TNF) | |
C07K14/525B: | . . . . Lymphotoxin (LT) | |
C07K14/52A: | . . . Chemokines | |
C07K14/52A1: | . . . . Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC | |
C07K14/52A2: | . . . . Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2 | |
C07K14/52B: | . . . Thrombopoietin, i.e. C-MPL ligand | |
C07K14/53: | . . . Colony-stimulating factor (CSF) | |
C07K14/535: | . . . . Granulocyte CSF; Granulocyte-macrophage CSF | |
C07K14/54: | . . . Interleukins (IL) | |
C07K14/545: | . . . . IL-1 | |
C07K14/54A: | . . . . IL-3 | |
C07K14/54B: | . . . . IL-4 | |
C07K14/54C: | . . . . IL-5 | |
C07K14/54D: | . . . . IL-6 | |
C07K14/54E: | . . . . Leukaemia inhibitory factor (LIF) | |
C07K14/54F: | . . . . IL-7 | |
C07K14/54G: | . . . . IL-8 | |
C07K14/54H: | . . . . IL-9 | |
C07K14/54K: | . . . . IL-10 | |
C07K14/54L: | . . . . IL-11 | |
C07K14/54M: | . . . . IL-12 | |
C07K14/54N: | . . . . IL-13 | |
C07K14/54P: | . . . . IL-14 | |
C07K14/54Q: | . . . . IL-15 | |
C07K14/54R: | . . . . IL-16 | |
C07K14/55: | . . . . IL-2 | |
C07K14/555: | . . . Interferons (IFN) | |
C07K14/56: | . . . . IFN-alpha | |
C07K14/565: | . . . . IFN-beta | |
C07K14/57: | . . . . IFN-gamma | |
C07K14/575: | . . Hormones | |
C07K14/575B: | . . . Corticotropin releasing factor (CRF) (Urotensin) | |
C07K14/575D: | . . . Placental lactogen; Chorionic somatomammotropin [M1204] | |
C07K14/575F: | . . . Calcitonin gene related peptide | |
C07K14/575G: | . . . Endothelin, vasoactive intestinal contractor (VIC) | |
C07K14/575H: | . . . Neuropeptide Y | |
C07K14/575K: | . . . Prolactin | |
C07K14/575L: | . . . Vasoactive intestinal peptide (VIP); Related peptides | |
C07K14/575M: | . . . Gastrin releasing peptide bombesin C07K7/08D | |
C07K14/575N: | . . . Thymosin; Related peptides | |
C07K14/575P: | . . . Products of obesity genes, e.g. leptin, obese (OB), tub, fat | |
C07K14/58: | . . . Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide (ANP); Cardionatrin; Cardiodilatin | |
C07K14/585: | . . . Calcitonins | |
C07K14/585A: | . . . . at least 1 amino acid in D-form | |
C07K14/58A: | . . . . at least 1 amino acid in D-form | |
C07K14/59: | . . . Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) | |
C07K14/595: | . . . Gastrins; Cholecystokinins (CCK) | |
C07K14/595A: | . . . . at least 1 amino acid in D-form | |
C07K14/59A: | . . . . at least 1 amino acid in D-form | |
C07K14/60: | . . . Growth-hormone releasing factors (GH-RF) (Somatoliberin) | |
C07K14/605: | . . . Glucagons | |
C07K14/61: | . . . Growth hormones (GH) (Somatotropin) | |
C07K14/615: | . . . . Extraction from natural sources | |
C07K14/62: | . . . Insulins | |
C07K14/625: | . . . . extraction from natural sources | |
C07K14/62A: | . . . . at least 1 amino acid in D-form | |
C07K14/63: | . . . Motilins | |
C07K14/635: | . . . Parathyroid hormone (parathormone); Parathyroid hormone-related peptides | |
C07K14/64: | . . . Relaxins | |
C07K14/645: | . . . Secretins | |
C07K14/65: | . . . Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2 | |
C07K14/655: | . . . Somatostatins | |
C07K14/655A: | . . . . at least 1 amino acid in D-form | |
C07K14/66: | . . . Thymopoietins | |
C07K14/665: | . . derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin | |
C07K14/66A: | . . . . at least 1 amino acid in D-form | |
C07K14/67: | . . . Lipotropins, e.g. beta, gamma lipotropin | |
C07K14/675: | . . . beta-Endorphins | |
C07K14/675A: | . . . . with at least 1 amino acid in D-form | |
C07K14/67A: | . . . . with at least 1 amino acid in D-form | |
C07K14/68: | . . . Melanocyte-stimulating hormone (MSH) | |
C07K14/685: | . . . . alpha-Melanotropin | |
C07K14/69: | . . . . beta-Melanotropin | |
C07K14/695: | . . . Corticotropin (ACTH) | |
C07K14/695A: | . . . . with at least 1 amino acid in D-form | |
C07K14/70: | . . . Enkephalins | |
C07K14/705: | . . Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/47A34 | |
C07K14/705B: | . . . Immunoglobulin superfamily | |
C07K14/705B10: | . . . . CD2 | |
C07K14/705B12: | . . . . T-cell receptor (TcR)-CD3 complex | |
C07K14/705B14: | . . . . CD4 | |
C07K14/705B16: | . . . . CD8 | |
C07K14/705B18: | . . . . CD28, CD152 | |
C07K14/705B20: | . . . . ICAM molecules, e.g. CD50, CD54, CD102 | |
C07K14/705B22: | . . . . CD58 | |
C07K14/705B24: | . . . . B7 molecules, e.g. CD80, CD86 | |
C07K14/705B26: | . . . . Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F) | |
C07K14/705B28: | . . . . MHC-molecules, e.g. HLA-molecules | |
C07K14/705B30: | . . . . CD106 | |
C07K14/705D: | . . . Integrin superfamily | |
C07K14/705D10: | . . . . Integrin beta1-subunit-containing molecules, e.g. CD29, CD49 | |
C07K14/705D12: | . . . . Integrin beta2-subunit-containing molecules, e.g. CD11, CD18 | |
C07K14/705D14: | . . . . Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61 | |
C07K14/705F: | . . . Lectin superfamily, e.g. CD23, CD72 | |
C07K14/705F10: | . . . . Selectins, e.g. CD62 | |
C07K14/705G: | . . . Nuclear receptors, e.g. retinoic acid receptor (RAR), RXR, nuclear orphan receptors | |
C07K14/705K: | . . . for neuromediators, e.g. serotonin receptor, dopamine receptor | |
C07K14/705Q: | . . . NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154 NGF C07K14/48, TNF C07K14/525 | |
C07K14/705R: | . . . NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95 NGF-receptor C07K14/71, TNF-receptor C07K14/715B | |
C07K14/705S: | . . . CD71 | |
C07K14/705T: | . . . CD44 | |
C07K14/705V: | . . . CD45 | |
C07K14/705W: | . . . CD52 | |
C07K14/705Z: | . . . Molecules with a "CD"-designation not provided for elsewhere | |
C07K14/70A: | . . . . with at least 1 amino acid in D-form | |
C07K14/71: | . . . for growth factors; for growth regulators | |
C07K14/715: | . . . for cytokines; for lymphokines; for interferons | |
C07K14/715B: | . . . . for tumor necrosis factor (TNF), for lymphotoxin (LT) | |
C07K14/715D: | . . . . for colony-stimulating factors (CSF) | |
C07K14/715F: | . . . . for interleukins (IL) | |
C07K14/715G: | . . . . for interferons (IFN) | |
C07K14/715H: | . . . . for chemokines | |
C07K14/72: | . . . for hormones for neuromediators C07K14/705K | |
C07K14/72A: | . . . . Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor | |
C07K14/72B: | . . . . G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor | |
C07K14/745: | . . Blood coagulation or fibrinolysis factors | |
C07K14/745B: | . . . Thrombomodulin | |
C07K14/75: | . . . Fibrinogen | |
C07K14/755: | . . . Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF) | |
C07K14/76: | . . Albumins | |
C07K14/765: | . . . Serum albumin, e.g. HSA | |
C07K14/77: | . . . Ovalbumin | |
C07K14/775: | . . Apolipopeptides | |
C07K14/78: | . . Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) | |
C07K14/785: | . . Alveolar surfactant peptides; Pulmonary surfactant peptides | |
C07K14/79: | . . Transferrins, e.g. lactoferrins, ovotransferrins | |
C07K14/795: | . Porphyrin- or corrin-ring-containing peptides | |
C07K14/80: | . . Cytochromes | |
C07K14/805: | . . Haemoglobins; Myoglobins | |
C07K14/81: | . Protease inhibitors | |
C07K14/815: | . . from leeches, e.g. hirudin, eglin | |
C07K14/81A: | . . Exopeptidase (E.C. 3.4.11-19) inhibitors | |
C07K14/81B: | . . Endopeptidase (E.C. 3.4.21-99) inhibitors | |
C07K14/81B1: | . . . Serine protease (E.C. 3.4.21) inhibitors | |
C07K14/81B1A: | . . . . Kunitz type inhibitors | |
C07K14/81B1A1: | . . . . . Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin) | |
C07K14/81B1B: | . . . . Serpins | |
C07K14/81B1B1: | . . . . . Alpha-1-antitrypsin | |
C07K14/81B1B2: | . . . . . Antithrombin III | |
C07K14/81B1B3: | . . . . . Plasminogen activator inhibitors | |
C07K14/81B1C: | . . . . Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid | |
C07K14/81B2: | . . . Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin | |
C07K14/81B3: | . . . Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors | |
C07K14/81B4: | . . . Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP | |
C07K14/82: | . Translation products from oncogenes | |
C07K14/825: | . Metallothioneins | |
C07K16/00: | Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/00B | |
C07K16/00A: | . constructed by phage libraries | |
C07K16/02: | . from eggs | |
C07K16/04: | . from milk | |
C07K16/06: | . from serum | |
C07K16/06A: | . . Purification, fragmentation | |
C07K16/08: | . against material from viruses | |
C07K16/08A: | . . from DNA viruses | |
C07K16/08A12: | . . . Hepadnaviridae, e.g. hepatitis B virus | |
C07K16/08A14: | . . . Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus | |
C07K16/08A16: | . . . Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus | |
C07K16/08A16B: | . . . . Herpes simplex virus | |
C07K16/08A16D: | . . . . Varicella-zoster virus, e.g. cytomegalovirus | |
C07K16/10: | . . from RNA viruses, e.g. hepatitis E virus | |
C07K16/10B: | . . . Picornaviridae, e.g. hepatitis A virus | |
C07K16/10D: | . . . Orthomyxoviridae, e.g. influenza virus | |
C07K16/10F: | . . . Paramyxoviridae, e.g. respiratory syncytial virus | |
C07K16/10K: | . . . Retroviridae, e.g. leukemia viruses | |
C07K16/10K1: | . . . . Lentiviridae, e.g. HIV, FIV, SIV | |
C07K16/10K1B: | . . . . . gag-pol, e.g. p17, p24 | |
C07K16/10K1D: | . . . . . env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site | |
C07K16/10K1F: | . . . . . Regulatory proteins, e.g. tat, rev, vpt | |
C07K16/10N: | . . . Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus | |
C07K16/10N1: | . . . . Hepatitis C virus; Hepatitis G virus | |
C07K16/12: | . against material from bacteria | |
C07K16/12A: | . . from Gram-negative bacteria | |
C07K16/12A10: | . . . from Spirochaetales (O), e.g. Treponema, Leptospira | |
C07K16/12A12: | . . . from Helicobacter (Campylobacter) (G) | |
C07K16/12A14: | . . . from Pseudomonadaceae (F) | |
C07K16/12A18: | . . . from Neisseriaceae (F), e.g. Acinetobacter | |
C07K16/12A22: | . . . from Brucella (G) | |
C07K16/12A24: | . . . from Bordetella (G) | |
C07K16/12A26: | . . . from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia | |
C07K16/12A26A: | . . . . from Escherichia (G) | |
C07K16/12A26C: | . . . . from Salmonella (G) | |
C07K16/12A28: | . . . from Vibrionaceae (G) | |
C07K16/12A30: | . . . from Pasteurellaceae (F), e.g. Haemophilus influenza | |
C07K16/12A32: | . . . from Rickettsiales (O) | |
C07K16/12A34: | . . . from Chlamydiales (O) | |
C07K16/12A36: | . . . from Mycoplasmatales, e.g. Pleuropneumonia-like organisms (PPLO) | |
C07K16/12A38: | . . . from Bacteridaceae (F) | |
C07K16/12A40: | . . . from Legionella (G) | |
C07K16/12A42: | . . . from Rhizobiaceae (F) | |
C07K16/12B: | . . from Gram-positive bacteria | |
C07K16/12B10: | . . . from Micrococcaceae (F), e.g. Staphylococcus | |
C07K16/12B12: | . . . from Streptococcus (G) | |
C07K16/12B14: | . . . from Bacillus (G) | |
C07K16/12B16: | . . . from Clostridium (G) | |
C07K16/12B20: | . . . from Corynebacterium (G) | |
C07K16/12B24: | . . . from Mycobacteriaceae (F) | |
C07K16/12B28: | . . . from Actinomyces; from Streptomyces (G) | |
C07K16/12B30: | . . . from Listeria | |
C07K16/14: | . against material from fungi, algea or lichens | |
C07K16/16: | . against material from plants | |
C07K16/18: | . against material from animals or humans | |
C07K16/20: | . . from protozoa | |
C07K16/20A: | . . . Plasmodium | |
C07K16/22: | . . against growth factors; against growth regulators | |
C07K16/24: | . . against cytokines, lymphokines or interferons | |
C07K16/24B: | . . . Tumor Necrosis Factors | |
C07K16/24B10: | . . . . Lymphotoxin (LT) | |
C07K16/24D: | . . . Colony Stimulating Factors | |
C07K16/24F: | . . . Interleukins (IL) | |
C07K16/24F1: | . . . . IL-1 | |
C07K16/24F2: | . . . . IL-2 | |
C07K16/24F4: | . . . . IL-4 | |
C07K16/24F6: | . . . . IL-6 | |
C07K16/24H: | . . . Interferons | |
C07K16/26: | . . against hormones; against hormone releasing or inhibiting factors | |
C07K16/28: | . . against receptors, cell surface antigens or cell surface determinants | |
C07K16/28A: | . . . against the immunoglobulin superfamily | |
C07K16/28A10: | . . . . against CD2 | |
C07K16/28A12: | . . . . [N. against the T-cell receptor (TcR)-CD3 complex] | |
C07K16/28A14: | . . . . against CD4 | |
C07K16/28A16: | . . . . against CD8 | |
C07K16/28A18: | . . . . against CD28 or CD152 | |
C07K16/28A20: | . . . . against ICAM molecules, e.g. CD50, CD54, CD102 | |
C07K16/28A22: | . . . . against CD58 | |
C07K16/28A24: | . . . . against B7 molecules, e.g. CD80, CD86 | |
C07K16/28A26: | . . . . against Fc-receptors, e.g. CD16, CD32, CD64 CD23 C07K16/28C | |
C07K16/28A28: | . . . . against MHC-molecules, e.g. HLA-molecules | |
C07K16/28A30: | . . . . against CD106 | |
C07K16/28B: | . . . against the integrin superfamily | |
C07K16/28B10: | . . . . against integrin beta1-subunit-containing molecules, e.g. CD29, CD49 | |
C07K16/28B12: | . . . . against integrin beta2-subunit-containing molecules, e.g. CD11, CD18 | |
C07K16/28B14: | . . . . against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61 | |
C07K16/28C: | . . . against the lectin superfamily, e.g. CD23, CD72 | |
C07K16/28C10: | . . . . against selectins, e.g. CD62 | |
C07K16/28D: | . . . against nuclear receptors, e.g. retinoic acid receptor (RAR), RXR, orphan receptor | |
C07K16/28F: | . . . against neuromediator receptors, e.g. serotonin receptor, dopamine receptor | |
C07K16/28G: | . . . against receptors for growth factors, growth regulators | |
C07K16/28H: | . . . against receptors for cytokines, lymphokines, interferons | |
C07K16/28K: | . . . against hormone receptors for antibodies against neuromediator receptors C07K16/28F | |
C07K16/28P: | . . . against prion molecules, e.g. CD230 | |
C07K16/28Q: | . . . against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154 against NGF C07K16/22, against TNF C07K16/24B | |
C07K16/28R: | . . . against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95 | |
C07K16/28S: | . . . against CD71 | |
C07K16/28T: | . . . against CD44 | |
C07K16/28U: | . . . [N: against CD20] | |
C07K16/28V: | . . . against CD45 | |
C07K16/28W: | . . . against CD52 | |
C07K16/28Z: | . . . against molecules with a "CD"-designation, not provided for elsewhere | |
C07K16/30: | . . . from tumour cells | |
C07K16/30A: | . . . . Carcino-embryonic Antigens | |
C07K16/30B: | . . . . Breast | |
C07K16/30D: | . . . . Lung | |
C07K16/30F: | . . . . Liver or Pancreas | |
C07K16/30H: | . . . . Kidney, bladder | |
C07K16/30K: | . . . . Stomach, Intestines | |
C07K16/30L: | . . . . Skin, nerves, brain | |
C07K16/30M: | . . . . Blood cells | |
C07K16/30P: | . . . . Reproductive system, e.g. ovaria, uterus, testes, prostate | |
C07K16/30S: | . . . . against structure-related tumour-associated moieties | |
C07K16/30S10: | . . . . . against tumour-associated gangliosides | |
C07K16/30S20: | . . . . . against tumour-associated mucins | |
C07K16/32: | . . against translation products of oncogenes | |
C07K16/34: | . . against blood group antigens | |
C07K16/36: | . . against blood coagulation factors | |
C07K16/38: | . against protease inhibitors of peptide structure | |
C07K16/40: | . against enzymes | |
C07K16/42: | . against immunoglobulins | |
C07K16/42K: | . . against an idiotypic determinant on Ig | |
C07K16/42K10: | . . . against anti-viral Ig | |
C07K16/42K10A: | . . . . against anti-HIV Ig | |
C07K16/42K12: | . . . against anti-bacterial Ig | |
C07K16/42K14: | . . . against anti-human or anti-animal Ig | |
C07K16/42K14A: | . . . . against anti-protozoal Ig | |
C07K16/42K14B: | . . . . against anti-receptor Ig | |
C07K16/42K14B1: | . . . . . against anti-tumor receptor Ig | |
C07K16/42K14B2: | . . . . . against anti-CD4 Ig | |
C07K16/42M: | . . against an allotypic or isotypic determinant on Ig | |
C07K16/42M10: | . . . against IgE | |
C07K16/44: | . against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids | |
C07K16/46: | . Hybrid immunoglobulins | |
C07K16/46B: | . . Igs containing Ig-regions, -domains or -residues form different species | |
C07K16/46B1: | . . . Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another | |
C07K16/46B2: | . . . Igs containing CDR-residues from one specie grafted between FR-residues from another | |
C07K16/46B2B: | . . . . with additional modified FR-residues | |
C07K16/46B3: | . . . Igs with modifications in the FR-residues only | |
C07K16/46D: | . . Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies | |
C07K17/00: | Carrier-bound or immobilised peptides ; Preparation thereof | |
C07K17/02: | . Peptides being immobilised on, or in, an organic carrier | |
C07K17/04: | . . entrapped within the carrier, e.g. gel, hollow fibre | |
C07K17/06: | . . attached to the carrier via a bridging agent | |
C07K17/08: | . . the carrier being a synthetic polymer | |
C07K17/10: | . . the carrier being a carbohydrate | |
C07K17/12: | . . . Cellulose or derivatives thereof | |
C07K17/14: | . Peptides being immobilised on, or in, an inorganic carrier | |
C07K19/00: | Hybrid peptides | |